ZFIN ID: ZDB-FIG-161227-19
Cortes et al., 2015 - Accumulation of the Vitamin D Precursor Cholecalciferol Antagonizes Hedgehog Signaling to Impair Hemogenic Endothelium Formation. Stem Cell Reports   5:471-9 Full text @ Stem Cell Reports
ADDITIONAL FIGURES
PHENOTYPE:
Fish:
Conditions:
Knockdown Reagent:
Observed In:
Stage: Prim-25

Fig. 2

D3 Negatively Regulates Hh-Mediated Vascular Niche Specification

(A) Gli:mCherry expression was decreased in D3-treated embryos compared to controls by WISH. Cyclopamine co-treatment caused synergistic reduction. Scale bar, 200 μm.

(B) Qualitative phenotypic distribution of embryos from (A) scored for gli:mcherry (n > 20 embryos/condition).

(C) Gli:mCherry FACS showed significant decreases in Hh responsive cells in D3 (54%, p = 0.006), cyclopamine (70%, ∗∗p = 0.001), or co-treated embryos (91%,∗∗∗p = 0.001) (5 embryos/sample × 4 replicates/condition). Error bars, mean ± SD.

(D) Qualitative phenotypic distribution of gli:mcherry expression in vdra morphants occurred in the presence or absence of D3 treatment (n > 20 embryos/condition).

(E) D3 reduced Notch reporter activity in intersomitic and axial vessels, similar to cyclopamine, by WISH. Co-treatment exacerbated Notch inhibition. Scale bar, 100 μm.

(F) Qualitative phenotypic distribution of embryos from (D) scored for Notch-GFP (n > 20 embryos/condition).

(G) SCL-GFP embryos treated with D3 (12–30 hpf) had reduced scl+ hemogenic endothelium by WISH for GFP. Scale as in (E).

(H) Qualitative phenotypic distribution of embryos from (F) scored for scl:GFP (n > 10 embryos/condition).

See also Figure S2.

Gene Expression Details No data available
Antibody Labeling Details No data available
Phenotype Details
Fish Conditions Stage Phenotype
nu15Tg chemical treatment by environment: Cyclopamine Prim-25 ventral wall of dorsal aorta has fewer parts of type hematopoietic multipotent progenitor cell, abnormal
Prim-25 ventral wall of dorsal aorta has fewer parts of type hematopoietic stem cell, abnormal
nu15Tg chemical treatment by environment: calciol Prim-25 ventral wall of dorsal aorta has fewer parts of type hematopoietic multipotent progenitor cell, abnormal
Prim-25 ventral wall of dorsal aorta has fewer parts of type hematopoietic stem cell, abnormal
nu15Tg chemical treatment by environment: Cyclopamine, chemical treatment by environment: calciol Prim-25 ventral wall of dorsal aorta lacks parts or has fewer parts of type hematopoietic multipotent progenitor cell, abnormal
Prim-25 ventral wall of dorsal aorta lacks parts or has fewer parts of type hematopoietic stem cell, abnormal
nu15Tg + MO2-vdra control Prim-25 ventral wall of dorsal aorta has extra parts of type hematopoietic multipotent progenitor cell, abnormal
Prim-25 ventral wall of dorsal aorta has extra parts of type hematopoietic stem cell, abnormal
nu15Tg + MO2-vdra chemical treatment by environment: calciol Prim-25 ventral wall of dorsal aorta has fewer parts of type hematopoietic multipotent progenitor cell, abnormal
Prim-25 ventral wall of dorsal aorta has fewer parts of type hematopoietic stem cell, abnormal
um14Tg chemical treatment by environment: Cyclopamine Prim-25 ventral wall of dorsal aorta has fewer parts of type hematopoietic multipotent progenitor cell, abnormal
Prim-25 ventral wall of dorsal aorta has fewer parts of type hematopoietic stem cell, abnormal
um14Tg chemical treatment by environment: calciol Prim-25 ventral wall of dorsal aorta has fewer parts of type hematopoietic multipotent progenitor cell, abnormal
Prim-25 ventral wall of dorsal aorta has fewer parts of type hematopoietic stem cell, abnormal
um14Tg chemical treatment by environment: Cyclopamine, chemical treatment by environment: calciol Prim-25 ventral wall of dorsal aorta lacks parts or has fewer parts of type hematopoietic multipotent progenitor cell, abnormal
Prim-25 ventral wall of dorsal aorta lacks parts or has fewer parts of type hematopoietic stem cell, abnormal
zf255Tg chemical treatment by environment: calciol Prim-25 ventral wall of dorsal aorta has fewer parts of type hematopoietic multipotent progenitor cell, abnormal
Prim-25 ventral wall of dorsal aorta has fewer parts of type hematopoietic stem cell, abnormal
Acknowledgments:
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Stem Cell Reports